1. Home
  2. AERT vs LITS Comparison

AERT vs LITS Comparison

Compare AERT & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

N/A

Current Price

$5.38

Market Cap

33.4M

ML Signal

N/A

LITS

Lite Strategy Inc.

N/A

Current Price

$1.01

Market Cap

36.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AERT
LITS
Founded
2012
2000
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.4M
36.3M
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
AERT
LITS
Price
$5.38
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.9K
★ 279.5K
Earning Date
11-12-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 110.87
13.81
EPS
0.27
★ 0.48
Revenue
★ $70,014,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.15
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.08
$0.69
52 Week High
$7.96
$2.26

Technical Indicators

Market Signals
Indicator
AERT
LITS
Relative Strength Index (RSI) 37.40 42.41
Support Level $3.97 $0.98
Resistance Level $7.19 $1.05
Average True Range (ATR) 0.38 0.09
MACD -0.04 -0.02
Stochastic Oscillator 4.46 23.44

Price Performance

Historical Comparison
AERT
LITS

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs. It has more than 40 clients spanning across industry segments.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients. The company operates in the segments: Digital Asset Treasury Strategy and Development of Pharmaceutical Products.

Share on Social Networks: